NNNN
$21.50
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.
Intraday
Recent News
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Most readers would already be aware that Anbio Biotechnology's (NASDAQ:NNNN) stock increased significantly by 18% over...
Anbio Biotechnology (NASDAQ:NNNN) Has A ROE Of 14%
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN)
Anbio Biotechnology (NASDAQ:NNNN) is one of the 13 Best German Stocks to Invest in Now. The company is engaged in the development of medical technology and the provision of in vitro diagnostics products. It was incorporated in 2021 and is based in Frankfurt. Anbio Biotechnology (NASDAQ:NNNN) had its initial public offering in February this year on […]
The IPO market in 2025 is being driven by a clear theme — bigger is better
The success of offerings like Circle, CoreWeave, and eToro Group — which all raised more than $600 million on their IPOs — is pushing leadership at private firms operating at that scale to move forward in the public offering process.
US Market's Undiscovered Gems and 2 Other Promising Small Caps
As the Dow Jones Industrial Average surges by more than 1,000 points, recovering from recent declines, and key indices like the S&P 500 and Nasdaq Composite also show significant gains, the U.S. market is experiencing a wave of optimism driven by earnings reports and tariff developments. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking to capitalize on potential growth; identifying undiscovered gems within these smaller companies can be an...